RECALL RECORD — CLASS IRecall closedF-0473-2022/FDA enforcement
Nutracap Labs LLC·Food·Nov 9, 2021

Healthy Habits GH3 Maxum Capsules 90ct Bottle

What you need to know

Class I
  • What happened

    During an FDA investigation the firm was notified that the product contains undeclared shellfish.

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. An allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

  • Action required

    Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction.

Recall closed · classified by the FDAAL, AR, AZ, CA +22 moreMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Match before you discard

Product identification

Source: FDA FOOD

Brand nameNutracap Labs LLC
Recalling firmNutracap Labs LLCNorcross, GA, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codes
  • LOT #2104120 EXP DATE 04/2023
Distribution area
ALARAZCACOCTFLGAIDILINKYLAMDMNNCNJNVNYOHORSCTNTXVAWA

Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, LA, MD, MN, NC, NJ, NV, NY, OH, OR, SC, TN, TX, VA & WA.

United States

Quantity affected80, 169 various bottles and jars
Recall initiationFDA report date: January 19, 2022
FDA recall numberF-0473-2022

Beyond the headline

The recall, in context

Nutracap Labs LLC initiated this food recall on November 9, 2021. The FDA enforcement report states: During an FDA investigation the firm was notified that the product contains undeclared shellfish. The FDA report lists distribution as: Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, FL, GA, ID, IL, IN, KY, LA, MD, MN, NC, NJ, NV, NY, OH, OR, SC, TN, TX, VA & WA.

The FDA enforcement report describes the reason as: During an FDA investigation the firm was notified that the product contains undeclared shellfish.

Healthy Habits GH3 Maxum Capsules 90ct Bottle was made or distributed by Nutracap Labs LLC in Norcross, GA, United States. This page reflects FDA report F-0473-2022, dated January 19, 2022.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, an allergen that is present but missing or incorrect on the label can cause a serious reaction in allergic consumers.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Undeclared allergen

Symptoms to watch for

Hives, swelling, wheezing, coughing, vomiting, abdominal pain or a drop in blood pressure. Anaphylaxis is a medical emergency.

When symptoms may appear

Allergic reactions often begin within minutes to a few hours of eating the allergen.

Higher-risk groups

Anyone with a diagnosed food allergy, especially children, and people with a history of anaphylaxis or asthma.

What to do now

  1. 1Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy.
  2. 2If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services.
  3. 3Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

For a severe allergic reaction, do not wait for a callback or refund process before seeking emergency care.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Healthy Habits GH3 Maxum Capsules 90ct Bottle recall?

Nutracap Labs LLC recalled Healthy Habits GH3 Maxum Capsules 90ct Bottle in an FDA Class I enforcement action reported as F-0473-2022. During an FDA investigation the firm was notified that the product contains undeclared shellfish.

What should I do if I bought this product?

Do not eat the product if you or someone in your household has a diagnosed allergy. Check the codes below, return it to the retailer for a refund, or dispose of it safely. Seek urgent care for signs of a severe allergic reaction. Do not eat or serve the affected product if you or anyone in the household has a diagnosed allergy. If symptoms such as swelling, wheezing or breathing difficulty occur, use the person's prescribed emergency plan and call emergency services. Keep the packaging, contact the retailer or manufacturer for a refund, and read the official recall notice for the exact allergen.

Is the Nutracap Labs LLC recall still active?

The FDA lists this recall as recall closed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record F-0473-2022. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Nutracap Labs LLC

View brand

Related alerts

Recent Undeclared allergens recalls

All alerts

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.